Dual-specificity tyrosine-(Y)-phosphorylation–regulated kinase 1A (DYRK1A); epidermal growth factor receptor (EGFR) BriefCommunication Pages: 459 - 459
β-Catenin (CTNNB1); HER2 (EGFR2; ErbB2; neu); p21 protein (Cdc42 Rac)-activated kinase 1 (PAK1) BriefCommunication Pages: 460 - 460
Enhancer of zeste homolog 2 (EZH2); SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily b member 1 (SMARCB1; SNF5) BriefCommunication Pages: 463 - 463
Insulin receptor substrate 1 (IRS1); phosphatidylinositol 3-kinase catalytic subunit α-polypeptide (PIK3CA; p110α); phosphoinositide 3-kinase-α (PI3Kα) BriefCommunication Pages: 464 - 464
Carcinoembryonic antigen–related cell adhesion molecule 6 (CEACAM6; NCA; CD66c) BriefCommunication Pages: 467 - 467
Mothers against decapentaplegic homolog 3 (MADH3; SMAD3); transforming growth factor receptor-β1 (TGFB1); vitamin D receptor (VDR) BriefCommunication Pages: 468 - 468
An aged mouse model for protein tyrosine phosphatase non-receptor type 22 (PTPN22; LYP)-associated autoimmunity BriefCommunication Pages: 474 - 474
Brain metastasis markers in epithelial cell adhesion molecule (EpCAM)− circulating tumor cells (CTCs) BriefCommunication Pages: 476 - 476
Using integrin α2 (VLA-2; CD49B) and lymphocyte-activation gene 3 (LAG3; CD223) to isolate type 1 Treg cells BriefCommunication Pages: 477 - 477